23 Einträge gefunden

1. VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma

   1. Schultze, Alexander
   2. Ben-Batalla, Isabella
   3. Riethdorf, Sabine
   4. Bubenheim, Michael
   5. Yekebas, Emre F.
   6. Erbersdobler, Andreas
   7. Reichelt, Uta

   2012 - Forschungsinformationssystem des UKE
2. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.

   1. Bokemeyer, Carsten
   2. Eric, Van Cutsem
   3. Rougier, Philippe
   4. Ciardiello, Fortunato
   5. Heeger, Steffen
   6. Schlichting, Michael
   7. Celik, Ilhan

   2012 - Forschungsinformationssystem des UKE
3. The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.

   1. Calabrò, Fabio
   2. Albers, Peter
   3. Bokemeyer, Carsten
   4. Martin, Chris
   5. Einhorn, Lawrence H
   6. Horwich, Alan
   7. Krege, Susanne

   2012 - Forschungsinformationssystem des UKE
4. PTEN deletion is rare but often homogeneous in gastric cancer.

   1. Mina, Sormeh
   2. Bohn, Benjamin
   3. Simon, Ronald
   4. Krohn, Antje
   5. Reeh, Matthias
   6. Arnold, Dirk
   7. Bokemeyer, Carsten

   2012 - Forschungsinformationssystem des UKE
5. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.

   1. Minner, Sarah
   2. Rump, Dorothea
   3. Tennstedt, Pierre
   4. Simon, Ronald
   5. Burandt, Eike Christian
   6. Terracciano, Luigi
   7. Moch, Holger

   2012 - Forschungsinformationssystem des UKE
6. Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.

   1. Canon, Jean-Luc
   2. Vansteenkiste, Johan
   3. Hedenus, Michael
   4. Gascon, Pere
   5. Bokemeyer, Carsten
   6. Ludwig, Heinz
   7. Vermorken, Jan

   2012 - Forschungsinformationssystem des UKE
7. The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature.

   1. Oliveira-Ferrer, Leticia
   2. Wellbrock, Jasmin
   3. Balabanov, Melanie
   4. Klockow, Marianne
   5. Hauschild, Jessica
   6. Bokemeyer, Carsten
   7. Fiedler, Walter

   2012 - Forschungsinformationssystem des UKE
8. Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab.

   1. Tejpar, Sabine
   2. Celik, Ilhan
   3. Schlichting, Michael
   4. Sartorius, Ute
   5. Bokemeyer, Carsten
   6. Eric, Van Cutsem

   2012 - Forschungsinformationssystem des UKE
9. Protein-protein-interaction network organization of the hypusine modification system.

   1. Sievert, Henning
   2. Venz, Simone
   3. Platas-Barradas, Oscar
   4. Dhople, Vishnu M
   5. Schaletzky, Martin
   6. Nagel, Claus-Henning
   7. Balabanov, Melanie

   2012 - Forschungsinformationssystem des UKE
10. Bone metastases in germ cell tumor patients.

    1. Oechsle, Karin
    2. Bokemeyer, Carsten
    3. Kollmannsberger, Christian
    4. Mayer, Frank
    5. Berger, Lars Arne
    6. Oing, Christoph
    7. Honecker, Friedemann

    2012 - Forschungsinformationssystem des UKE
11. Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor.

    1. Langer, Florian
    2. Bokemeyer, Carsten

    2012 - Forschungsinformationssystem des UKE
12. Is advanced cancer associated with demoralization and lower global meaning? The role of tumor stage and physical problems in explaining existential distress in cancer patients.

    1. Vehling, Sigrun
    2. Lehmann, Claudia
    3. Oechsle, Karin
    4. Bokemeyer, Carsten
    5. Krüll, Andreas
    6. Koch-Gromus, Uwe
    7. Mehnert, Anja

    2012 - Forschungsinformationssystem des UKE
13. Reduced CD151 expression is related to advanced tumour stage in urothelial bladder cancer

    1. Minner, Sarah Jane Pauline
    2. De Silva, Colin
    3. Rink, Michael
    4. Dahlem, Roland
    5. Chun, Felix
    6. Fisch, Margit
    7. Höppner, Wolfgang

    2012 - Forschungsinformationssystem des UKE
14. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

    1. Lorch, Anja
    2. Kleinhans, Antje
    3. Kramar, Andrew
    4. Kollmannsberger, Christian K
    5. Hartmann, Jörg T
    6. Bokemeyer, Carsten
    7. Rick, Oliver

    2012 - Forschungsinformationssystem des UKE
15. Evaluation of BM cytomorphology after allo-SCT in patients with AML

    1. Christopeit, M
    2. Miersch, K
    3. Klyuchnikov, Evgeny
    4. Haferlach, T
    5. Binder, Mascha
    6. Zabelina, Tatjana
    7. Ayuketang Ayuk, Francis

    2012 - Forschungsinformationssystem des UKE
16. Succinate reverses in-vitro platelet inhibition by acetylsalicylic acid and P2Y receptor antagonists.

    1. Spath, Brigitte
    2. Hansen, Arne
    3. Bokemeyer, Carsten
    4. Langer, Florian

    2012 - Forschungsinformationssystem des UKE
17. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

    1. Preukschas, Michael
    2. Hagel, Christian
    3. Schulte, Alexander
    4. Riecken, Kristoffer
    5. Lamszus, Katrin
    6. Sievert, Henning
    7. Pällmann, Nora

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
18. Critical imbalance of TNF-α and soluble TNF receptor 1 in a patient with macrophage activation syndrome: potential implications for diagnostics and treatment.

    1. Flammiger, Anna
    2. Fiedler, Walter
    3. Bacher, Ulrike
    4. Bokemeyer, Carsten
    5. Schneider, Marion
    6. Binder, Mascha

    2012 - Forschungsinformationssystem des UKE
19. Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair.

    1. Fenske, Annabelle E
    2. Glaesener, Stephanie
    3. Bokemeyer, Carsten
    4. Thomale, Juergen
    5. Dahm-Daphi, Jochen
    6. Honecker, Friedemann
    7. Dartsch, Dorothee C

    2012 - Forschungsinformationssystem des UKE
20. Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.

    1. Voigt, Mareike
    2. Braig, Friederike
    3. Goethel, Markus
    4. Schulte, Alexander
    5. Lamszus, Katrin
    6. Bokemeyer, Carsten
    7. Binder, Mascha

    2012 - Forschungsinformationssystem des UKE - frei zugänglich